The 48 rating InvestorsObserver gives to I-Mab ADR (IMAB) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 53 percent of stocks in the Biotechnology industry, IMAB’s 48 overall rating means the stock scores better than 48 percent of all stocks.
IMAB has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on IMAB!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 48 means the stock is more attractive than 48 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With I-Mab ADR Stock Today?
I-Mab ADR (IMAB) stock is trading at $5.50 as of 2:52 PM on Wednesday, Jan 4, a rise of $1.26, or 29.72% from the previous closing price of $4.24. The stock has traded between $4.25 and $5.66 so far today. Volume today is above average. So far 2,247,654 shares have traded compared to average volume of 558,485 shares.
Click Here to get the full Stock Report for I-Mab ADR stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
